Kunxian capsule alleviates podocyte injury and proteinuria by inactivating β-catenin in db/db mice

Kunxian capsule alleviates podocyte injury and proteinuria by inactivating β-catenin in db/db mice

BackgroundDiabetic kidney disease (DKD) remains the primary cause of end-stage renal disease (ESRD) globally, but treatment options are limited. Kunxian capsule (KXC) has been utilized for the treatment of autoimmune diseases and IgA nephropathy in China. However, its effect on DKD remains poorly in...

Full description

Bibliographic Details
Main Authors:	Bo Jin, Jing Liu, Yan Zhu, Jian Lu, Qingyan Zhang, Yan Liang, Qiuyuan Shao, Chunming Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Medicine
Subjects:	Kunxian capsule diabetic kidney disease podocyte β-Catenin epithelial-to-mesenchymal transition
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1213191/full

Similar Items

Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy
by: Jia Lv, et al.
Published: (2025-02-01)

Efficacy and safety of Kunxian in IgA nephropathy
by: Yang Yang, et al.
Published: (2025-03-01)

Long noncoding RNA MEG3 suppresses podocyte injury in diabetic nephropathy by inactivating Wnt/β-catenin signaling
by: Xiajing Che, et al.
Published: (2019-11-01)

Acteoside protects podocyte against apoptosis through regulating AKT/GSK-3β signaling pathway in db/db mice
by: Xiaoya Li, et al.
Published: (2023-10-01)

Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease
by: Le Gong, et al.
Published: (2023-12-01)

suPAR and WT1 modify the adhesion of podocytes and are related to proteinuria in class IV lupus nephritis
by: Juan-José Bollain-y-Goytia, et al.
Published: (2023-12-01)

Metformin Protects against Podocyte Injury in Diabetic Kidney Disease
by: Sanna Lehtonen
Published: (2020-12-01)

Quantifying Podocyte Number in a Small Sample Size of Glomeruli with CUBIC to Evaluate Podocyte Depletion of db/db Mice
by: Jiaoyu Shi, et al.
Published: (2023-01-01)

Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation
by: Wang L, et al.
Published: (2023-06-01)

Huaiqihuang may protect from proteinuria by resisting MPC5 podocyte damage via targeting p-ERK/CHOP pathway
by: Tingxia Li, et al.
Published: (2016-08-01)

New insights into the immune functions of podocytes: the role of complement
by: Valentina Bruno, et al.
Published: (2023-04-01)

Nonimmunologic targets of immunosuppressive agents in podocytes
by: Tae-Hyun Yoo, et al.
Published: (2015-06-01)

Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism
by: Li Lin, et al.
Published: (2023-11-01)

Pharmacological Blockade of the Adenosine A<sub>2B</sub> Receptor Is Protective of Proteinuria in Diabetic Rats, through Affecting Focal Adhesion Kinase Activation and the Adhesion Dynamics of Podocytes
by: Pablo Mendoza-Soto, et al.
Published: (2024-05-01)

Cyclosporine A Protects Podocytes by Regulating Transgelin in Adriamycin-Induced Podocyte Injury
by: Xiaoyan Li, et al.
Published: (2024-07-01)

The Physiopathologic Roles of Calcium Signaling in Podocytes
by: Yu-Chi Tu, et al.
Published: (2023-10-01)

Podocyte infolding glomerulopathy; current concepts
by: Azadeh Khayyat, et al.
Published: (2023-03-01)

Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy
by: Linlin Sun, et al.
Published: (2023-02-01)

Tim-1 alleviates lupus nephritis-induced podocyte injury via regulating autophagy
by: Yunxia Yu, et al.
Published: (2021-10-01)

Over-expression of APMAP alleviates glomerular podocyte injury in adriamycin nephropathy
by: WU Jingyi, FAN Wenjing, YAN Donghua
Published: (2023-12-01)

Mogroside IIIE Alleviates High Glucose-Induced Inflammation, Oxidative Stress and Apoptosis of Podocytes by the Activation of AMPK/SIRT1 Signaling Pathway
by: Xue W, et al.
Published: (2020-10-01)

Protective Role of Tangshen Formula on the Progression of Renal Damage in db/db Mice by TRPC6/Talin1 Pathway in Podocytes
by: Qian Wang, et al.
Published: (2020-01-01)

Role of Arginase-II in Podocyte Injury under Hypoxic Conditions
by: Zhilong Ren, et al.
Published: (2022-08-01)

Modeling Podocyte Ontogeny and Podocytopathies with the Zebrafish
by: Bridgette E. Drummond, et al.
Published: (2023-02-01)

Interleukin-13 Increases Podocyte Apoptosis in Cultured Human Podocytes
by: Keum Hwa Lee, et al.
Published: (2018-04-01)

Podocyte senescence: from molecular mechanisms to therapeutics
by: Qian Zhao, et al.
Published: (2024-12-01)

Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis
by: Natasha de Zoysa, et al.
Published: (2024-03-01)

Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition
by: Qiong‐ Dan Hu, et al.
Published: (2023-11-01)

Regulation of the Actin Cytoskeleton in Podocytes
by: Judith Blaine, et al.
Published: (2020-07-01)

PFKFB3 downregulation aggravates Angiotensin II-induced podocyte detachment
by: Xiaoxiao Huang, et al.
Published: (2023-12-01)

Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy
by: Wang T, et al.
Published: (2019-09-01)

Mitofusin2 expression is associated with podocyte injury in IgA nephropathy
by: Xuanli Tang, et al.
Published: (2023-03-01)

Beta-Catenin in Pseudoexfoliation Syndrome
by: Joanna Stafiej, et al.
Published: (2020-09-01)

Engineering antioxidant ceria-zirconia nanomedicines for alleviating podocyte injury in rats with adriamycin-induced nephrotic syndrome
by: Lili Liu, et al.
Published: (2023-10-01)

Effect of Sirt1 on high glucose-induced exosome release from podocytes
by: DING Lin, ZHOU Yan, LIU Shanshan, LIU Nanchi, MA Ruixia
Published: (2024-02-01)

The Role of α3β1 Integrin Modulation on Fabry Disease Podocyte Injury and Kidney Impairment
by: Bruna Bosquetti, et al.
Published: (2023-12-01)

Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy
by: Hong Jiang, et al.
Published: (2024-01-01)

Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease
by: Lingfeng Zeng, et al.
Published: (2024-01-01)

Quantification of urinary podocyte‐derived migrasomes for the diagnosis of kidney disease
by: Rong Yang, et al.
Published: (2024-06-01)

Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond
by: Matthew Tolerico, et al.
Published: (2024-05-01)